Tenders Are Invited For Pharmaceutical Products – Open House Agreements 2026 - Aflibercept (Copy)

Pharmaceutical Products – Open House Agreements 2026 - Aflibercept (Copy). In The Open House Procedure, Medicines According To The Bfarm List According To Section 35 Para. 5A Sgb V (Childrens Medicines) Are Excluded. The Subject Of This Publication Is The Conclusion Of Contracts In Accordance With Section 130A Paragraph 8 Sgb V For Various Active Ingredients As Part Of A So-Called Open House Procedure. Subject To Uniform Contractual Conditions And A Uniform Access Procedure, All Suitable And Interested Pharmaceutical Companies Or Communities Of Pharmaceutical Companies Are Offered The Opportunity To Conclude Or Join A Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Named Active Ingredient. The Earliest Contract Start Date Is November 1St, 2026 And The Contract End Date Is November 30Th, 2028. Joining This Open House Process Is Possible At Any Time Within The Contract Period. If You Are Interested, Please Be So Kind As To Send Us The Discount Agreement Signed In Duplicate By Email In Advance, Taking Into Account The Bfarms List Of Childrens Medicines.